These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subjects at risk of discontinuation of lipid-lowering agents: a 6-month cohort study among 12,875 patients in a chinese population. Wong MC, Jiang JY, Yan BP, Griffiths SM. Clin Ther; 2011 May; 33(5):617-28. PubMed ID: 21665046 [Abstract] [Full Text] [Related]
3. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study. Wong MC, Jiang JY, Griffiths SM. Clin Ther; 2009 Oct; 31(10):2170-7; discussion 2150-1. PubMed ID: 19922888 [Abstract] [Full Text] [Related]
8. Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study. Wong MC, Jiang JY, Griffiths SM. J Clin Pharmacol; 2010 May; 50(5):598-605. PubMed ID: 19897763 [Abstract] [Full Text] [Related]
9. Factors associated with compliance to thiazide diuretics among 8551 Chinese patients. Wong MC, Jiang JY, Griffiths SM. J Clin Pharm Ther; 2011 Apr; 36(2):179-86. PubMed ID: 21366647 [Abstract] [Full Text] [Related]
11. Treating hypertension. Are the right drugs given to the right patients? Beaulieu MD, Dufresne L, LeBlanc D. Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833 [Abstract] [Full Text] [Related]
14. Comparing the cumulative incidences of add-on therapy among the major antihypertensive classes in 2531 Asian patients: a cohort study. Wong MC. J Clin Pharm Ther; 2010 Apr; 35(2):201-5. PubMed ID: 20456739 [Abstract] [Full Text] [Related]
15. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction. Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C. Clin Ther; 2008 Apr; 30 Pt 2():2217-27. PubMed ID: 19281916 [Abstract] [Full Text] [Related]
19. Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors. Mahmoudpour SH, Asselbergs FW, de Keyser CE, Souverein PC, Hofman A, Stricker BH, de Boer A, Maitland-van der Zee AH. Int J Clin Pharm; 2015 Dec; 37(6):1095-103. PubMed ID: 26159317 [Abstract] [Full Text] [Related]